News
-
-
PRESS RELEASE
EQS-Adhoc: PAUL Tech AG: Approval of decision to refinance existing EUR 35m 7% 2020/2025 bond through Issue of a Nordic bond
PAUL Tech AG approves to refinance existing EUR 35m 7% 2020/2025 bond through issuance of Nordic bond. Pareto Securities & B. Metzler appointed as coordinators. Market launch today -
-
-
PRESS RELEASE
Informations privilégiées / Information sur chiffre d’affaires annuel
MaaT Pharma publie ses résultats semestriels 2025 et réalise un point sur ses activités, incluant des résultats positifs d'essais cliniques et des accords stratégiques, renforçant sa position financière et opérationnelle -
-
-
-
PRESS RELEASE
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Sanofi's brivekimig shows positive results in phase 2a study for hidradenitis suppurativa, presenting clinically meaningful improvements in primary and secondary endpoints in biologic-naïve patients -